Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Blood|September 15, 2020
The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLsLeandro Venturutti, Ari M Melnick
Breast Cancer Research : BCR|May 16, 2012
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer developmentMartin A Rivas, Leandro Venturutti, Yi-Wen Huang, et al.
Breast Cancer Research : BCR|December 7, 2014
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growthFranco Izzo, Florencia Mercogliano, Leandro Venturutti, et al.
FEBS Open Bio|August 17, 2013
The role of the N-terminal tail for the oligomerization, folding and stability of human frataxinSantiago E Faraj, Leandro Venturutti, Ernesto A Roman, et al.
Cancer Immunology Research|November 21, 2025
Phenotypic characterization and prognostic impact of CD103+ tissue-resident memory T cells in diffuse large B cell lymphomaGillian Savage, Katy Milne, Brett Collinge, et al.
Molecular Endocrinology (Baltimore, Md.)|September 5, 2015
Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer GrowthCecilia J Proietti, Franco Izzo, María Celeste Díaz Flaqué, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 13, 2024
Profiling Dynamic Patterns of Single-Cell MotilityDebonil Maity, Nikita Sivakumar, Pratik Kamat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast CancerMaría F Mercogliano, Mara De Martino, Leandro Venturutti, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2024
TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphomaMichael Y Li, Lauren C Chong, Gerben Duns, et al.
BMC Cancer|December 29, 2017
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancerMaría F Mercogliano, Gloria Inurrigarro, Mara De Martino, et al.
Pageof 2